Abstract The number of genetically defined Primary Immunodeficiency Diseases (PID) has increased exponentially, especially in the past decade. The biennial classification published by the IUIS PID expert committee is therefore quickly expanding, providing valuable information regarding the disease-causing genotypes, the immunological anomalies, and the associated clinical features of PIDs. These are grouped in eight, somewhat overlapping, categories of immune dysfunction. However, based on this immunological classification, the diagnosis of a specific PID from the clinician's observation of an individual clinical and/or immunological phenotype remains difficult, especially for non-PID specialists. The purpose of this work is to suggest a phenotypic classification that forms the basis for diagnostic trees, leading the physician to particular groups of PIDs, starting from clinical features and combining routine immunological investigations along the way. We present 8 colored diagnostic figures that correspond to the 8 PID groups in the IUIS Classification, including all the PIDs cited in the 2011 update of the IUIS classification and most of those reported since.
, at an even faster pace since the advent of next-generation sequencing, the classification and these tables are therefore cumbersome. They offer limited assistance to most physicians at the bedside, especially those outside the field of PIDs and those in training; clinicians in regions Patients with a PID may first present to many types of medical and surgical disciplines and this is likely to be increasingly common given the growing number of patients with known or suspected PIDs [7] . Such physicians, who may lack familiarity with PIDs, need a classification that is based on a clinical and/or biological phenotype that they observe. This prompted IUIS PID experts to work on a simplified classification, based on simple clinical and immunological phenotypes, in order to provide some easy-to-follow algorithms to diagnose a particular PID or group of PIDs. This will optimize collaboration between primary centers and specialized centers, particularly for genetic studies, and will lead to faster and more precise molecular diagnosis and genetic counseling, paving the way to more appropriate management of affected patients and families. This work presents a user-friendly classification of PIDs, providing a tree-based decisionmaking process based on the observation of clinical and biological phenotypes.
Methodology
We included all diseases from the 2011 update of IUIS PID classification [1] . To stay up-to-date, we also included new diseases described in the last 2 years [2] . However, there may be other genes associated with PIDs that are not included here to be faithful to our inclusion criteria. An algorithm was assigned to each of the eight main groups of the classification. We used the same color for each group of similar conditions. Disease names are written in red. As in the IUIS Classification, an asterisk is added to highlight extremely rare disorders (less than 10 cases reported in the medical literature). These algorithms were first established by a small committee; then validated by one or two experts for each figure.
Results
A classification validated by the IUIS PID expert committee is presented in Figs. 1, 2, 3, 4 , 5, 6, 7 and 8.
Discussion
These figures are diagnostic tools that represent a modified and simplified version of the 2011 IUIS classification [1] . They are based on patients' clinical and biological phenotypes and are mostly presented as decision trees for diagnostic orientation. These figures serve as diagnostic orientation tools for the typical forms of PID; the more atypical presentations of PIDs are not covered in these figures. These figures do not therefore aim to replace decisional trees or diagnostic protocols proposed by other teams or scientific societies [8] [9] [10] [11] . Rather they aim at being a user-friendly first approach to the IUIS classification [1] . These figures enable non-PID specialists to select the most appropriate diagnostic tree and to undertake some preliminary investigations, whilst contacting an expert in PIDs. They may also help in the selection of the center or expert to whom the patient should be referred, given the patient's particular phenotype. In all cases, whether a tentative diagnosis can be made based on these figures or not, we recommend that the practitioner outside the field who sees a patient with a possible PID seeks specialist advice.
To simplify our figures, we did not systematically include all data from the IUIS classification (OMIM number, presumed pathogenesis, affected cells or function…) [1] . In order to present the 24 pages from the IUIS classification in only 8 figures, we used common abbreviations familiar to most physicians (explained in footnotes). The use of a color code makes these figures easy to follow, so that they could be hung, in larger format, in clinical wards. This is also suitable for informing young clinicians and students.
To make these figures easier to use by clinicians and biologists, we highlighted the clinical and biological features, adding to the data from the IUIS classification some other features typical of the PID in question. This allows an initial orientation towards a particular disease or group of diseases. Whenever it was possible, we have focused on clinical or routine laboratory features that distinguish disorders that are closely related. Example: A female infant with an opportunistic infection in whom lymphocyte subpopulation investigation reveals profound CD3 and CD16/56 lymphopenia without CD19/20 lymphopenia has a SCID T-B+NK-phenotype, which strongly suggests Jak3 deficiency (Fig. 1) . After discussion with a team specialized in the diagnosis and treatment of SCID patients, an analysis of the JAK3 gene will be arranged as a priority, while expert advice will be given on the appropriate management for the infant.
Though atypical forms of PID are increasingly reported in the literature [12] [13] [14] [15] , typical presentations of these conditions remain predominant, permitting this classification to be useful in most of cases. Moreover, the genetic heterogeneity of most PIDs is high and patients with almost any PID may lack coding mutations in known disease-causing genes. This manuscript will therefore be up-dated every other year along with the IUIS classification. Meanwhile, we hope that this phenotypic approach to diagnosis of PID can constitute a useful tool for physicians or biologists from various related specialties, especially in the setting of pediatric and adult medicine (internal medicine, pulmonology, hematology, oncology, immunology, infectious diseases, etc…) who may encounter the first presentation of PID patients.
Conclusion
The strengths of this algorithmic approach to the diagnosis of PID are its simplified format, reliance on phenotypic features, presentation in user-friendly pathways, and validation by a group of PID experts. We hope they will be useful to physicians at the bedside in several areas of pediatrics, internal medicine, and surgery. While these algorithms cannot be comprehensive, due to the tremendous genetic and phenotypic heterogeneity of PIDs, they will be improved over time with progress in the field as well as by feed-back from users. They will also be expanded with the discovery of new PIDs and the refined description of known PIDs.
